Among children and adolescents with type 1 diabetes mellitus, the use of insulin pump therapy has increased since its introduction in the early 1980s. Optimal management of type 1 diabetes mellitus depends on sufficient understanding by patients, their families, and healthcare providers on how to use pump technology. The goal for the use of insulin pump therapy should be to advance proficiency over time from the basics taught at the initiation of pump therapy to utilizing advanced settings to obtain optimal glycemic control. However, this goal is often not met, and appropriate understanding of the full features of pump technology can be lacking. The objective of this review is to provide an expert perspective on the advanced features and use of insulin pump therapy, including practical guidelines for the successful use of insulin pump technology, and other considerations specific to patients and healthcare providers.
Get full access to this article
View all access options for this article.
References
1.
American Diabetes Association: Standards of medical care in diabetes—2016. Chapter 11: Children and Adolescents. Diabetes Care, 2016; 39(suppl 1):S86–S93.
2.
FairchildJ: Changes in management and outcomes for children and adolescents with type 1 diabetes over the last 50 years. J Paediatr Child Health, 2015; 51:122–125.
3.
GianiE, ScaramuzzaAE, ZuccottiGV: Impact of new technologies on diabetes care. World J Diabetes, 2015; 6:999–1004.
4.
LarsonNS, PinskerJE: The role of continuous glucose monitoring in the care of children with type 1 diabetes. Int J Pediatr Endocrinol, 2013; 2013:8.
5.
HinshawL, Dalla ManC, NandyDK, et al.: Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes, 2013; 62:2223–2229.
6.
AndersenAJ, OstenfeldA, PipperCB, et al.: Optimum bolus wizard settings in insulin pumps in children with Type 1 diabetes. Diabet Med, 2016; 33:1360–1365.
7.
RamotowskaA, GolickiD, DzygaloK, et al.: The effect of using the insulin pump bolus calculator compared to standard insulin dosage calculations in patients with type 1 diabetes mellitus—systematic review. Exp Clin Endocrinol Diabetes, 2013; 121:248–254.
8.
DriscollKA, JohnsonSB, WangY, et al.: Importance of manually entering blood glucose readings when wireless-compatible meters are not being used with an insulin pump. J Diabetes Sci Technol, 2013; 7:898–903.
9.
ToffaninC, ZisserH, DoyleFJ3rd, DassauE: Dynamic insulin on board: incorporation of circadian insulin sensitivity variation. J Diabetes Sci Technol, 2013; 7:928–940.
RevertA, CalmR, VehiJ, et al.: Calculation of the best basal-bolus combination for postprandial glucose control in insulin pump therapy. IEEE Trans Biomed Eng, 2011; 58:274–281.
12.
PankowskaE, SzypowskaA, LipkaM, et al.: Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes. Pediatr Diabetes, 2009; 10:298–303.
SorliC, HeileMK: Identifying and meeting the challenges of insulin therapy in type 2 diabetes. J Multidiscip Healthc, 2014; 7:267–282.
15.
JoubertM, ReznikY: Personal continuous glucose monitoring (CGM) in diabetes management: review of the literature and implementation for practical use. Diabetes Res Clin Pract, 2012; 96:294–305.
16.
HiroseM, BeverlyEA, WeingerK: Quality of life and technology: impact on children and families with diabetes. Curr Diab Rep, 2012; 12:711–720.
17.
WongJC, FosterNC, MaahsDM, et al.: Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care, 2014; 37:2702–2709.
18.
DeSalvoD, BuckinghamB: Continuous glucose monitoring: current use and future directions. Curr Diab Rep, 2013; 13:657–662.
19.
PattonSR, ClementsMA: Continuous glucose monitoring versus self-monitoring of blood glucose in children with type 1 diabetes—are there pros and cons for both?. US Endocrinol, 2012; 8:27–29.
20.
BaileyTS, GrunbergerG, BodeBW, et al.: American Association of Clinical Endocrinologists and American College of Endocrinology 2016 Outpatient Glucose Monitoring Consensus Statement. Endocr Pract, 2016; 22:231–261.
21.
DovčK, BratinaN, BattelinoT: A new horizon for glucose monitoring. Horm Res Paediatr, 2015; 83:149–156.
22.
BodeBW: Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. Clin Ther, 2007; 29(suppl D):S135–S144.
23.
ChuL, HamiltonJ, RiddellMC: Clinical management of the physically active patient with type 1 diabetes. Phys Sportsmed, 2011; 39:64–77.
24.
KovatchevBP, PatekSD, OrtizEA, et al.: Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Diabetes Technol Ther, 2015; 17:177–186.
25.
RiddellMC, MillikenJ: Preventing exercise-induced hypoglycemia in type 1 diabetes using real-time continuous glucose monitoring and a new carbohydrate intake algorithm: an observational field study. Diabetes Technol Ther, 2011; 13:819–825.
26.
KeenanDB, CartayaR, MastrototaroJJ: Accuracy of a new real-time continuous glucose monitoring algorithm. J Diabetes Sci Technol, 2010; 4:111–118.
27.
KalraS, MukherjeeJJ, VenkataramanS, et al.: Hypoglycemia: the neglected complication. Indian J Endocrinol Metab, 2013; 17:819–834.
28.
KennyC: When hypoglycemia is not obvious: diagnosing and treating under-recognized and undisclosed hypoglycemia. Prim Care Diabetes, 2014; 8:3–11.
29.
McGarraughG: Alarm characterization for a continuous glucose monitor that replaces traditional blood glucose monitoring. J Diabetes Sci Technol, 2010; 4:49–56.
30.
AgrawalP, ZhongA, WelshJB, et al.: Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps. Diabetes Technol Ther, 2015; 17:316–319.
31.
BergenstalRM, KlonoffDC, GargSK, et al.: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med, 2013; 369:224–232.
32.
WeissR, GargSK, BergenstalRM, et al.: Predictors of hypoglycemia in the ASPIRE In-Home Study and effects of automatic suspension of insulin delivery. J Diabetes Sci Technol, 2015; 9:1016–1020.
33.
WeissR, GargSK, BodeBW, et al.: Hypoglycemia reduction and changes in hemoglobin A1c in the ASPIRE In-Home Study. Diabetes Technol Ther, 2015; 17:542–547.
34.
ChoudharyP, ShinJ, WangY, et al.: Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care, 2011; 34:2023–2025.
35.
CampbellMS, SchatzDA, ChenV, et al.: A contrast between children and adolescents with excellent and poor control: the T1D Exchange clinic registry experience. Pediatr Diabetes, 2014; 15:110–117.
36.
BodeBW, SabbahHT, GrossTM, et al.: Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev, 2002; 18(suppl 1):S14–S20.
37.
KawamuraT: The importance of carbohydrate counting in the treatment of children with diabetes. Pediatr Diabetes, 2007; 8(suppl 6):57–62.
38.
GökşenD, Atik AltinokY, OzenS, et al.: Effects of carbohydrate counting method on metabolic control in children with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol, 2014; 6:74–78.
39.
SchmidtS, ScheldeB, NorgaardK: Effects of advanced carbohydrate counting in patients with type 1 diabetes: a systematic review. Diabet Med, 2014; 31:886–896.
40.
SmartCE, RossK, EdgeJA, et al.: Can children with Type 1 diabetes and their caregivers estimate the carbohydrate content of meals and snacks?. Diabet Med, 2010; 27:348–353.
41.
RiddellMC, GallenIW, SmartCE, et al.: Exercise management in type 1 diabetes: a consensus statement. Lancet Diabetes Endocrinol, 2017; In press.
42.
VanelliM, CorchiaM, IovaneB, et al.: Self-monitoring adherence to physical activity in children and adolescents with type 1 diabetes. Acta Biomed, 2006; 77(suppl 1):47–50.
43.
FaheyPJ, StallkampET, KwatraS: The athlete with type I diabetes: managing insulin, diet and exercise. Am Fam Physician, 1996; 53:1611–1624.
44.
Mauvais-JarvisF, SobngwiE, PorcherR, et al.: Glucose response to intense aerobic exercise in type 1 diabetes: maintenance of near euglycemia despite a drastic decrease in insulin dose. Diabetes Care, 2003; 26:1316–1317.
45.
GuelfiKJ, JonesTW, FournierPA: New insights into managing the risk of hypoglycaemia associated with intermittent high-intensity exercise in individuals with type 1 diabetes mellitus: implications for existing guidelines. Sports Med, 2007; 37:937–946.
46.
Tamis-JortbergB, DownsDAJr., ColtenME: Effects of a glucose polymer sports drink on blood glucose, insulin, and performance in subjects with diabetes. Diabetes Educ, 1996; 22:471–487.
47.
HuangS, WelshJB, LeeSW, et al.: ASPIRE In-Clinic Study Group. Exercise-induced hypoglycemia in the ASPIRE in-clinic study: lessons learned. Poster 971-P. June21–25, 2013. Chicago, Il. 2013 [cited May26, 2016]. www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=648a0362-2cc5-4aaa-849d-efc0f5ed13c3&cKey=ba411285-a213-49e4-bd20-12b89b8fc702&mKey=%7b89918D6D-3018-4EA9-9D4F-711F98A7AE5D%7d. Accessed January16, 2017.
48.
TaplinCE, CobryE, MesserL, et al.: Preventing post-exercise nocturnal hypoglycemia in children with type 1 diabetes. J Pediatr, 2010; 157:784–788.e1.
49.
CoriglianoG, IazzettaN, CoriglianoM, et al.: Blood glucose changes in diabetic children and adolescents engaged in most common sports activities. Acta Biomed, 2006; 77(suppl 1):26–33.
50.
BodeBW, KylloJ, KaufmanFR: Medtronic Pumping Protocol: A Guide to Insulin Pump Therapy Initiation. 2011. https://s3.amazonaws.com/medtronic-hcp/Pumping%20Protocol%20-%20a%20Guide%20to%20Insulin%20Pump%20Therapy%20Initiation.pdf.
51.
KaufmanFR, WestfallE: How to use continuous glucose monitors and pumps. Insulin Pumps and Continuous Glucose Monitoring: A User's Guide to Effective Diabetes Management. American Diabetes Association, Alexandria, VA; 2012:176.
52.
KaufmanFR, WestfallE: Understanding the impact of physical activity. Insulin Pumps and Continuous Glucose Monitoring: A User's Guide to Effective Diabetes Management. American Diabetes Association, Alexandria, VA; 2012:90–93.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
